HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

(4R,12AS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12A-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxamide

HCID 53469002
NotesReactions
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1335210-35-9
Standard SMILES
COc1c2n(cc(C(=O)NCc3ccc(F)cc3F)c1=O)C[C@@H]1OCC[C@@H](C)N1C2=O
InChIKey
MOSMLVZNRGURDI-BZNIZROVSA-N
Molecular formula
C21H21F2N3O5
Average molar mass
433.4 g/mol
Monoisotopic mass
433.1449271

Names & identifiers

Preferred name
(4R,12AS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12A-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxamide
IUPAC
(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-methoxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
English name
O-Methyl Dolutegravir
Molecular formula
C21H21F2N3O5
Molecular weight
433.41

Names & synonyms

1335210-35-9(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide(4R,12AS)-N-((2,4-DIFLUOROPHENYL)METHYL)-3,4,6,8,12,12A-HEXAHYDRO-7-METHOXY-4-METHYL-6,8-DIOXO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZINE-9-CARBOXAMIDERefChem:403306838-070-7(4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide(4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamideMFCD29059073(3S,7R)-N-[(2,4-Difluorophenyl)methyl]-11-methoxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-, (4R,12aS)-Dolutegravir O-Methyl ImpurityGYK3AEV9WP

Properties

Computed structural properties

XLogP
2.2
Topological polar surface area
88.2 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
8
Rotatable bonds
4
Heavy atoms
31
Formal charge
0
Complexity
845

Physicochemical properties

Boiling point
684.3 · 684.3±55.0 °C(Predicted)
Density
1.45 · 1.45±0.1 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
pka
10.7 · 10.70±0.40(Predicted)
Appearance
Off-white to light yellow Solid
InChIKey
MOSMLVZNRGURDI-BZNIZROVSA-N
SMILES
O1CC[C@@H](C)N2C(=O)C3=C(OC)C(=O)C(C(NCC4=CC=C(F)C=C4F)=O)=CN3C[C@]12[H]
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338
HS Code
38220090 · 38220090

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P233, P260, P261, P264, P264+P265, P270, P271, P272, P273, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P391, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (50%)

Safety data

hs_code
38220090
Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Applications · 2 items

DescriptionDolutegravir intermediate is a new synthetic intermediate of Dolutegravir. Dolutegravir is an integrase inhibitor used to treat human immunodeficiency virus (HIV)-1 infection.

Uses(4R,12AS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide is an intermediate in the preparation of dolutegravir, an integrase inhibitor for HIV-1 infection therapy.

Upstream & downstream products

Upstream raw materials

(4R,12aS)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid2,4-Difluorobenzylamine

Downstream products

Dolutegravir sodium

Suppliers64 total

陕西缔都新材料有限公司81124267 17392282731 · [email protected]
上海策嵘生物科技有限公司[email protected]
济南百隆化学有限公司[email protected] · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Show more names
BNKY001-DL03O-Methyl DolutegravirDoultegravir O- methylDolutegravir O-Methyl ImpDolutegravir methyl ImpurityDoultegravir O methyl impurity(4r,12as)-n-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexa...
SCHEMBL15082128SCHEMBL29815007C21H21F2N3O5AKOS027339712DS-12374CS-0186080F11522F626308

Database identifiers

CAS
1335210-35-9
PubChem CID
53469002
UNII
GYK3AEV9WP
EC Number
838-070-7
Nikkaji
J3.782.746K
广州佳途科技股份有限公司81960175-877 18933936954 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
Shanghai Yingrui Biopharma Co.,Ltd21-33585366 · [email protected]
普善实业(陕西)有限公司029-81310890 18165209495 · [email protected]
Nanjing Fred Technology Co., Ltd+86-25-84696168 +86-15380713688 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
深圳市简一生物科技有限公司0755-84826604 · [email protected]
山东大有药物研发有限公司[email protected] 15165037910 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
湖北魏氏化学试剂股份有限公司027-59102966 18717199209 · [email protected]
南京诺利斯医药科技有限公司13901585132 · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
NANJING YINGWEN BIOTECHNOLOGY CO LTD+8613382787392 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
广州九植医药科技有限公司020-89854820 · [email protected]
上海升华医药科技有限公司021-50793966 18917198199 · [email protected]
郑州泰丰制药有限公司182-3786-0830 19913859908 · [email protected]
大赛璐药物手性技术(上海)有限公司021-50460086-9 15921403865 · [email protected]
深圳市洛克医药科技有限公司13128912434 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]
南京诺利斯医药科技有限公司13901585132 · [email protected]
深圳市华先医药科技有限公司Q:3003761227 17722620669 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
陕西晶和医药科技有限公司029-86062279 13324594253 · [email protected]
Chongqing jooe co., ltd+86-15223382610 · [email protected]
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD+8613676922317 · [email protected]
HANGZHOU LEAP CHEM CO., LTD.+86-571-87711850 +86-15355479329 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
上海德轩医药科技有限公司[email protected] · [email protected]
Standardpharm Co. Ltd.86-714-3992388 · [email protected]
sgtlifesciences pvt ltd+91-8790379245 · [email protected]
上海润栖医药科技有限公司021-38751876 15000076078 · [email protected]
上海炎泽化工有限公司15345144255 19901447308 · [email protected]
湖北威德利化学试剂有限公司15871722230 · [email protected]
郑州艾克姆化工有限公司0371-0371-55629727 13323845623 · [email protected]
西安莱茵生物科技有限公司86-(0)29-85992781 17792393971 · [email protected]
苏州莱惠生物技术有限公司180-1316-0973 · [email protected]
湖北鑫源顺医药化工有限公司027-50664929, 13971561712 · [email protected]
湖北扬信医药科技有限公司15374522761 · [email protected]
上海策嵘生物科技有限公司(定制合成实验室)13917420128 13062833949 · [email protected]
Novachemistry44-20819178-90 02081917890 · [email protected]
广州万仟医药科技有限公司020-84886379 13928768873 · [email protected]
Capot Chemical Co.,Ltd.+86-(0)57185586718 +86-13336195806 · [email protected]